On 18 October 2019, the Company announced the acquisition of Love Hemp Ltd (“Love Hemp”). The terms of the acquisition (the “Initial Terms”) made provision for deferred consideration of up to a maximum of £4,000,000 to be paid to the vendors of Love Hemp (the “Sellers”) as follows

  • £1,500,000 in cash on the date falling six months and one day from the date of completion, provided that at the Company’s election it could alternatively pay to the Sellers an amount equal to £2,000,000 to be satisfied by the issue of ordinary shares of 1p each in the Company (“Ordinary Shares”) calculated on a 10 per cent discount to the 10-day VWAP preceding the date of the issue of those shares (the “First Deferred Payment”); and
  • £1,500,000 in cash on the date falling twelve months and one day from the date of completion, provided that at the Company’s election it could alternatively pay to the Sellers an amount equal to £2,000,000 to be satisfied by the issue of Ordinary Shares calculated on a 10 per cent discount to the 10-day VWAP preceding the date of the issue of those shares

Pursuant to the Initial Terms, the Company was required either to pay the Sellers £1,500,000 in cash on 16 April 2020 or, within two business days of this date, to issue the Ordinary Shares to satisfy the First Deferred Payment. On 18 April 2020, the Company notified the Sellers that they would issue the Ordinary Shares to satisfy the First Deferred Payment but until this time they have not done so as they have been in active discussions with the Sellers as to varying the Initial Terms. The Company has today entered into a deed of variation with the Sellers to vary the Initial Terms (the “Revised Terms”) so that the Sellers shall instead be paid as follows:


  • 22,222,222 Ordinary Shares (“First Deferred Payment Shares”) shall be issued and allotted to the Sellers on 25 September 2020 in their relevant proportions at a price per share of 9p. Pursuant to an escrow agreement also entered into today, the share certificates relating to the First Deferred Payment Shares shall be held by an escrow agent and the First Deferred Payment Shares may not be disposed of by the Sellers until the earlier of:
    • the termination of the relevant Seller’s employment contract or any extension thereof;
    • the date three days before the closing date of the sale of the Seller’s ordinary shares to a third party purchaser; or
    • at the request of the Seller, on the closing date of the sale or merger of the Company which results in new shareholders owning more than 51 per cent of the entire issued share capital of the Company
  • £1,500,000 in cash on 15 January 2021, provided that at the Sellers’ election it can alternatively pay to the Sellers an amount equal to £2,000,000 to be satisfied by the issue of Ordinary Shares calculated on a 10 per cent discount to the 10-day VWAP preceding the date of the issue of those shares

Tony Calamita and Thomas Rowland are the principal Sellers, and have each been allotted 10,000,000 of the First Deferred Payment Shares, such that each now has an interest in 23,500,000 Ordinary Shares, representing in each case 12.2 per cent of the Company’s enlarged issued share capital.

As announced by the Company on 9 March 2020, the Company has raised £2,355,782 (before expenses) through the issue of convertible loans and convertible debentures (“Convertible Loan Notes”) which are convertible into Ordinary Shares at a price of 10p per share at the election of the holders. The Company has now received notice from one of the holders electing to convert £12,121 into 121,210 Ordinary Shares at 10p per share and the Company has elected to convert the interest owing of £1,073 into a further 17,877 Ordinary Shares at 6p per share to issue in aggregate 139,087 Ordinary Shares (“Conversion Shares”).

In addition, the Company has today issued and allotted 680,778 Ordinary Shares to certain advisers in settlement of fees at a price per share of 7.3p (“Adviser Shares”)

Application will be made for the First Deferred Payment Shares, the Conversion Shares and the Adviser Shares to be admitted to trading on the AQSE Growth Market and admission is expected to become effective on 1 October 2020.

Following the issue of the First Deferred Payment Shares, the Conversion Shares and the Adviser Shares, the Company has 192,005,534 Ordinary Shares in issue, each share carrying the right to one vote. The figure of 192,005,534 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

The Directors of the Company accept responsibility for the contents of this announcement.

About Love Hemp

Love Hemp is one of the UK’s leading CBD and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products. Love Hemp has established relationships with over 1,200 stores in the UK, including leading brands such as Ocado, Holland & Barrett and WH Smith.

About World High Life

World High Life was established by the founders of Supreme Cannabis (TSX: FIRE), and 1933 Industries (CSE: TGIF), both companies at the forefront of the legalized cannabis industry. LIFE was established to take advantage of the huge opportunities available in the UK and European legal cannabis space, which is set to be the largest in the world within five years.

For further information please contact:

David Stadnyk
Founder & CEO
World High Life Plc
+44 (0) 7926 397 675
info@worldhighlife.uk

AQSE Exchange Corporate Adviser
Mark Anwyl/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7469 0930
ma@peterhousecap.com
af@peterhousecap.com

Financial PR
Megan Ray / Madeleine Gordon-Foxwell
Blytheweigh
+44 (0) 20 7138 3222
Megan.Ray@blytheweigh.com
Madeleine.Gordon-Foxwell@blytheweigh.com

For more information on World High Life please visit: www.wordhighlife.uk

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Cautionary Note Regarding Forward Looking Information

We seek safe harbour. Some statements contained in this news release are “forward looking information” within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management’s current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Antony Luigi Calamita

2

Reason for the notification

a)

Position/status

Managing Director, Love Hemp Ltd

b)

Initial notification /Amendment

Amendment

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

World High Life Plc

b)

LEI

213800ERYVHIGFSPMM75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1 pence each

ISIN: GB00BMDY1P48

b)

Nature of the transaction

Deferred consideration

c)

Price(s) and volume(s)

Price (p) 9p per share

Number of Ordinary Shares: 10,000,000

d)

Aggregated information

– Aggregated volume

– Price

Issuance of 10,000,000 Ordinary Shares at 9p per share at an aggregate value of £900,000

e)

Date of the transaction

25 September 2020

f)

Place of the transaction

AQSE Growth Market (AQSE)

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Thomas Mark Rowland

2

Reason for the notification

a)

Position/status

Chief Operating Officer, Love Hemp Ltd

b)

Initial notification /Amendment

Amendment

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

World High Life Plc

b)

LEI

213800ERYVHIGFSPMM75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1 pence each

ISIN: GB00BMDY1P48

b)

Nature of the transaction

Deferred consideration

c)

Price(s) and volume(s)

Price (p) 9p per share

Number of Ordinary Shares: 10,000,000

d)

Aggregated information

– Aggregated volume

– Price

Issuance of 10,000,000 Ordinary Shares at 9p per share at an aggregate value of £900,000

e)

Date of the transaction

25 September 2020

f)

Place of the transaction

AQSE Growth Market (AQSE)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: World High Life Plc

View source version on accesswire.com:
https://www.accesswire.com/607768/World-High-Life-PLC-Announces-Deferred-Consideration-and-Issue-of-Equity

News Provided by ACCESSWIRE via QuoteMedia

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peabody Energy Corporation (NYSE: BTU), Tactile Systems Technology, Inc. (NASDAQ: TCMD), Pintec Technology Holdings Limited (NASDAQ: PT), and Aurora Cannabis, Inc. (NYSE: ACB). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Peabody Energy Corporation (NYSE: BTU)

Keep reading... Show less

 GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company”) announces it has granted stock options to acquire a total of 1,400,000 common shares of the Company to various directors, officers, and consultants of the Company pursuant to its Stock Option Plan. The options are exercisable at a price of $0.10 per share and expire three years from the date of grant. The options are subject to vesting provisions where 1,000,000 options will vest immediately and 400,000 options will vest 25% per quarter commencing October 31, 2020.

About GreenStar

Keep reading... Show less

 GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company”) announces it has granted stock options to acquire a total of 1,400,000 common shares of the Company to various directors, officers, and consultants of the Company pursuant to its Stock Option Plan. The options are exercisable at a price of $0.10 per share and expire three years from the date of grant. The options are subject to vesting provisions where 1,000,000 options will vest immediately and 400,000 options will vest 25% per quarter commencing October 31, 2020.

About GreenStar

Keep reading... Show less

Block & Leviton LLP ( www.blockleviton.com ), a national securities litigation firm, reminds investors that securities class actions have been filed against GoHealth, Inc. (NASDAQ: GOCO), NextCure, Inc. (NASDAQ: NXTC), and Aurora Cannabis Inc. (NYSE: ACB). Shareholders interested in serving as lead plaintiff have until the deadlines listed below to move the court. Further details about the cases are described below. There is no cost or obligation to you.

GOCO Shareholders – Click Here: https://www.blockleviton.com/cases/goco

Keep reading... Show less

** THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES .**

Harvest Health & Recreation Inc. (” Harvest ” or the ” Company “)  ( CSE: HARV ), a vertically integrated cannabis company and multi-state operator in the U.S., is pleased to announce that, further to its news releases dated October 21, 2020 and October 22, 2020  the Company has completed its previously announced bought deal public offering of 20,354,080 units (the ” Units “), including 2,654,880 Units issued pursuant to the Underwriters’ (as defined herein) over-allotment option which was exercised in full by notice to the Company, at a price of $2.26 per Unit (the ” Offering Price “), for aggregate gross proceeds of $46,000,220.80 (the ” Offering “) (All figures are in Canadian dollars unless otherwise stated).

Keep reading... Show less